| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8316214 | Clinica Chimica Acta | 2011 | 6 Pages |
Abstract
The presented results indicate that assessments of circulating TN-C levels may help to identify EDMD patients at risk of dilated cardiomyopathy. TN-C might therefore be considered a candidate for a new biomarker, useful in detecting of cardiomyopathy and in further monitoring of the DCM therapy in patients with EDMD.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Irena Niebroj-Dobosz, Agnieszka Madej-Pilarczyk, MichaÅ Marchel, Beata SokoÅowska, Irena Hausmanowa-Petrusewicz,